| 1. |
Chong JJ, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature, 2014, 510(7504): 273-277.
|
| 2. |
Wang Y, Liang P, Lan F, et al. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. J Am Coll Cardiol, 2014, 64(5): 451-459.
|
| 3. |
Liang P, Lan F, Lee AS, et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation, 2013, 127(16): 1677-1691.
|
| 4. |
Lan F, Lee AS, Liang P, et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell, 2013, 12(1): 101-113.
|
| 5. |
Burridge PW, Keller G, Gold JD, et al. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell, 2012, 10(1): 16-28.
|
| 6. |
Lian X, Hsiao C, Wilson G, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA, 2012, 109(27): E1848-E1857.
|
| 7. |
Kadari A, Mekala S, Wagner N, et al. Robust generation of cardiomyocytes from human iPS cells requires precise modulation of BMP and WNT signaling. Stem Cell Rev, 2015, 11(4): 560-569.
|
| 8. |
Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol, 2007, 25(9): 1015-1024.
|
| 9. |
Burridge PW, Matsa E, Shukla P, et al. Chemically defined generation of human cardiomyocytes. Nat Methods, 2014, 11(8): 855-860.
|
| 10. |
Elliott DA, Braam SR, Koutsis K, et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods, 2011, 8(12): 1037-1040.
|
| 11. |
Burridge PW, Thompson S, Millrod MA, et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One, 2011, 6(4): e18293.
|
| 12. |
Cao N, Liu Z, Chen Z, et al. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res, 2012, 22(1): 219-236.
|
| 13. |
Takahashi T, Lord B, Schulze PC, et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, 2003, 107(14): 1912-1916.
|
| 14. |
楊梁, 張曉剛, 魏新偉. 維生素C體外誘導多能干細胞向心肌細胞的分化. 中國組織工程研究與臨床康復, 2011, 15(23): 4229-4232.
|
| 15. |
穆軍升, 李獻帥, 袁樹民, 等. 直接貼壁法誘導人胚胎干細胞分化為心肌細胞. 中國胸心血管外科臨床雜志, 2013, 20(5): 564-569.
|
| 16. |
李獻帥, 袁樹民, 穆軍升, 等. 懸浮培養誘導人胚胎干細胞分化為心肌細胞的研究. 心肺血管病雜志, 2014, 33(1): 93-97.
|